These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23327506)

  • 21. Does cannabis testing in the military drive synthetic cannabinoid use? Self-reported use motivations among justice-involved veterans.
    Santangelo O; Baldwin JM; Stogner J
    Int J Drug Policy; 2022 Aug; 106():103756. PubMed ID: 35738030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Spice in France: mixed herbs containing synthetic cannabinoids].
    Schlatter J; Chiadmi F; Chariot P
    Ann Biol Clin (Paris); 2012; 70(4):413-22. PubMed ID: 22796613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychotic Disorders in Patients Who Use Synthetic Cannabinoids.
    Skryabin VY; Vinnikova MA
    J Psychiatr Pract; 2019 Nov; 25(6):485-490. PubMed ID: 31821228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabis, cannabinoids and schizophrenia: integration of the evidence.
    Cohen M; Solowij N; Carr V
    Aust N Z J Psychiatry; 2008 May; 42(5):357-68. PubMed ID: 18473254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic cannabinoids: the dangers of spicing it up.
    Salani DA; Zdanowicz MM
    J Psychosoc Nurs Ment Health Serv; 2015 May; 53(5):36-43. PubMed ID: 25974923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoids and psychosis.
    D'Souza DC
    Int Rev Neurobiol; 2007; 78():289-326. PubMed ID: 17349865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spice: a legal marijuana equivalent.
    Johnson LA; Johnson RL; Alfonzo C
    Mil Med; 2011 Jun; 176(6):718-20. PubMed ID: 21702397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemorrhagic Soft Tissue Upper Airway Obstruction From Brodifacoum-Contaminated Synthetic Cannabinoid.
    Ross CH; Singh P; Simon EL
    J Emerg Med; 2019 Jul; 57(1):47-50. PubMed ID: 31078349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychosis associated with synthetic cannabinoid agonists: a case series.
    Hurst D; Loeffler G; McLay R
    Am J Psychiatry; 2011 Oct; 168(10):1119. PubMed ID: 21969050
    [No Abstract]   [Full Text] [Related]  

  • 31. From "herbal highs" to the "heroin of cannabis": Exploring the evolving discourse on synthetic cannabinoid use in a Norwegian Internet drug forum.
    Bilgrei OR
    Int J Drug Policy; 2016 Mar; 29():1-8. PubMed ID: 26860324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
    Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
    Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Psychoses from cannabis--case reports].
    Tunving K
    Lakartidningen; 1976 Nov; 73(45):3872-3. PubMed ID: 979454
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacological properties and dependence liabilities of synthetic cannabinoids].
    Funada M
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Jun; 45(3):167-74. PubMed ID: 20681249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products.
    Winstock AR; Barratt MJ
    Hum Psychopharmacol; 2013 Jul; 28(4):390-3. PubMed ID: 23881887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis and psychosis: what do we know and what should we do?
    Colizzi M; Murray R
    Br J Psychiatry; 2018 Apr; 212(4):195-196. PubMed ID: 29557759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Spiceophrenia": a systematic overview of "spice"-related psychopathological issues and a case report.
    Papanti D; Schifano F; Botteon G; Bertossi F; Mannix J; Vidoni D; Impagnatiello M; Pascolo-Fabrici E; Bonavigo T
    Hum Psychopharmacol; 2013 Jul; 28(4):379-89. PubMed ID: 23881886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic cannabinoid induced psychosis in a previously nonpsychotic patient.
    Peglow S; Buchner J; Briscoe G
    Am J Addict; 2012; 21(3):287-8. PubMed ID: 22494236
    [No Abstract]   [Full Text] [Related]  

  • 39. "Spice" girls: synthetic cannabinoid intoxication.
    Schneir AB; Cullen J; Ly BT
    J Emerg Med; 2011 Mar; 40(3):296-9. PubMed ID: 21167669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The intersection between cannabis and cancer in the United States.
    Bowles DW; O'Bryant CL; Camidge DR; Jimeno A
    Crit Rev Oncol Hematol; 2012 Jul; 83(1):1-10. PubMed ID: 22019199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.